Speaker illustration

Doctor Dimitrios Konstantinidis

Hippokration General Hospital, Athens (Greece)

Isolated systolic hypertension versus combined systolic-diastolic hypertension as predictors of atrial fibrillation: Data from a 8-year-follow-up study

Event: ESC CONGRESS 2019

Topic: Clinical

Session: Syncope and bradycardia

Thumbnail

Isolated systolic hypertension and combined systolic-diastolic hypertension for prediction of new-onset diabetes mellitus: Data from a 8-year-follow-up study

Event: ESC Congress 2018

Topic: Diabetes and the Heart, Other

Session: Diabetes, obesity and metabolic syndrome

Thumbnail

Comparison of the predictive role of changes in left ventricular mass and arterial stiffness for coronary artery disease in essential hypertension: data from a greek 8-year-follow-up study

Event: ESC Congress 2018

Topic: Target Organ Damage/Left Ventricular Hypertrophy

Session: Best Posters in hypertension and arterial stiffness

Thumbnail

Isolated systolic hypertension versus combined systolic-diastolic hypertension as predictors of atrial fibrillation: Data from a Greek 8-year-follow-up study

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: Atrial fibrillation mechanisms

Thumbnail

Relationship between Retinal arteriopathy and left ventricular hypertrophy in newly diagnosed essential hypertension patients.

Event: ESC CONGRESS 2016

Topic: Haemodynamics, heart and hypertension

Session: Hypertension-Haemodynamics and genetics

Thumbnail

Waist circumference versus other obesity parameters as prognosticators of coronary artery disease in essential hypertension

Event: ESC CONGRESS 2016

Topic: Nutrition

Session: Balanced nutrition - Mission impossible?

Thumbnail

Determinants of left ventricular hypertrophy apart from hypertension

Event: ESC CONGRESS 2016

Topic: Echo-ventricular function

Session: Echo-Doppler - Other

Thumbnail

Predictors of new-onset atrial fibrillation in essential hypertensives

Event: ESC CONGRESS 2016

Topic: Haemodynamics, heart and hypertension

Session: Target organ damage in hypertension

Thumbnail

This platform is supported by

logo Novo Nordisk